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F
or engineered materials (such as metals, ceramics and compos-
ites), fatigue is by far the most common cause of failure. In frac-
ture-mechanics terms, fatigue implies the decrease of a material’s 
mechanical resistance as a result of the repetitive (cyclic) application 
of a load that by itself is not sufficient to cause the static failure of 
the material. Fatigue failure is defined as the number of cycles or 
time needed to reach a predefined level of material damage or crack 
growth. In the case of an engineered structure (such as a bridge), 
the structure is not only designed to resist a maximum static load 
but, more importantly, to also support a certain number of loading 
cycles (caused by daily traffic, for example) before it requires repair. 
Although these concepts are widely and practically implemented by 
civil engineers, the same ideas have not yet been thoroughly inte-
grated into the understanding of bone as a structural material, or into 
the clinical prevention of fragility fractures in human populations. In 
bone research, the predominant fracture mechanism is still uncer-
tain: are bones more prone to fracture by a fatigue mechanism under 
cyclic loading, as are most engineered materials, or are they more 
inclined to break in a static-fracture mode by a single overload, as has 
been implied in a majority of the research on bone fragility1?
Persuasive evidence that the mechanisms of fatigue-driven crack 
growth are extensively involved in bone fracture began to emerge 
approximately a century ago. At that time, the medical term ‘stress 
fracture’ (Box 1) was applied to describe injuries associated with 
military personnel and athletes who abruptly engaged in a regimen 
of marching or running2–4. Such injuries are now clinically termed 
fatigue fractures (Box 1), and are now recognized as one of the most 
common type of fractures involved in all sports injuries (~0.7 to 
20%)5,6. Although most research on fatigue-induced fracture was 
dedicated to study healthy bone from soldiers and athletes7–11, another 
type of fatigue-induced fracture, clinically termed insufficiency frac-
tures (Box 1), is now becoming more apparent. Insufficiency frac-
tures are caused by habitual daily loading in the elderly (which, in the 
context of this Perspective, we define as people older than approxi-
mately 50 years) or in patients with bone fragility12–16.
In healthy bone, microdamage accumulates slowly during cyclic 
loading and has sufficient time to undergo repair17–20. In contrast, 
either the rapid growth of fatigue microdamage or insufficient 
repair eventually causes catastrophic failure18,20. In age-related and 
bone-fragility diseases, factors such as changes in bone mass, in 
bone quality at multiple length scales and in bone repair rates pro-
vide the basis for increased accumulation of damage that leads to 
insufficiency fractures21–23.
Improved imaging techniques have increased clinical aware-
ness in that a proportion of fragility fractures might actually be 
insufficiency fractures24. Insufficiency fractures are most often 
associated with osteoporosis, but are also apparent in diseases 
such as rheumatoid arthritis, Paget’s disease, osteomalacia, osteo-
genesis imperfecta and diabetes25. Certain therapies, such as pelvic 
irradiation and drug treatment, or poor nutrition and hormonal 
imbalance, can also promote insufficiency fractures. Even rare 
but serious complications of long-term bisphosphonate treatment 
(the controversial ‘atypical femoral fractures’) are thought to be 
insufficiency fractures26–30. However, quantifying the extent to 
which fractures of cortical bone result from cyclic fatigue dam-
age in live individuals is a difficult exercise. Fatigue mechanisms 
occur at nanometre to micrometre length scales over long peri-
ods of time, and involve numerous confounding factors, such as 
loading history and patient history, bone mass, bone quality and 
cellular bone repair.
The diversity of fractures observed in human bone is not cur-
rently matched by an equally sophisticated understanding of the 
underlying biological or mechanical mechanisms. Improved under-
standing could impact the clinical approach to diagnosis or treat-
ment. Therefore, in an attempt to explore the role of fatigue in bone, 
in this Perspective we raise and discuss the following points:
?? To what extent does daily cyclic loading (rather than single 
overload events) contribute to fragility fractures? How can such 
fatigue damage be detected and characterized?
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The prevention of fragility fractures in bone—pathologic fractures resulting from daily activity and mostly occurring in the 
elderly population—has been a long-term clinical quest. Recent research indicating that falls in the elderly might be the conse-
quence of fracture rather than its cause has raised fundamental questions about the origin of fragility fractures. Is day-to-day 
cyclic loading, instead of a single-load event such as a fall, the main cause of progressively growing fractures? Are fragility 
fractures predominantly affected by bone quality rather than bone mass, which is the clinical indicator of fracture risk? Do 
osteocytes actively participate in the bone repair process? In this Perspective, we discuss the central role of cyclic fatigue in 
bone fragility fracture.
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?? To what extent does the reduced quality of fragile bone aect 
fatigue resistance?
?? What are the cellular mechanisms by which fatigue damage 
stimulates local repair? What is the role of osteocytes in such 
repair? How do these repair processes vary with time?
?? Does microdamage resulting from cyclic loading prevent or 
promote stress fractures?
The emerging awareness of insufficiency fractures
The early stages of an insufficiency fracture are accompanied by peri-
osteal reaction oedema and bone marrow oedema, followed by the 
appearance of subtle linear fracture lines and the formation of a cal-
lus to heal the fracture site31. Clinically, most insufficiency fractures 
are reported in patients over 60 years of age, especially in women 
with postmenopausal osteoporosis25, 32,33. However, the true preva-
lence of insufficiency fractures in the elderly is unknown. The lack 
of a systematic assessment of their incidence is due to three main 
reasons. First, although insufficiency fractures have a distinct fail-
ure pattern, they do not have a diagnosis code of their own. Several 
clinical terms are used to describe insufficiency fractures, and these 
terms are often interchanged. These include spontaneous fractures, 
minimal-trauma fractures, low-energy fractures, pathologic frac-
tures, fragility fractures and compression fractures. This confusion 
in terminology illustrates one difficulty in identifying insufficiency 
fractures. Second, the primary clinical symptom of insufficiency 
fractures, pain, is often vague and can easily be attributed to other 
pathologic conditions in the elderly. Consequently, physicians do not 
always make the link between pain and bone fragility resulting from 
insufficiency fracture14. The third reason is that the early stages of 
stress fracture, characterized by oedema and hairline cracks resulting 
from fatigue damage, are particularly difficult to detect with ordi-
nary radiographic imaging. Alternative imaging techniques—such 
as magnetic resonance imaging (MRI), high-resolution computed 
tomography, bone scanning and scintigraphy25,34—are more sensitive 
for the detection of the associated marrow oedema but they usually 
do not have adequate resolution to detect a fatigue crack of a few 
micrometres in width35,36. Moreover, these tests are not regularly used 
to detect fractures in the context of advanced age. Once the critical 
crack size is reached and the final separation of the bone has occurred 
by brittle or catastrophic fracture, it is particularly challenging to dis-
cern whether the fracture was the result of an insufficiency fracture 
induced by cyclic loading or of an overload fracture induced by a 
single impact. In materials science, fractographic analysis (that is, the 
study of fracture surfaces) would be used to determine the origin 
of failure; however, the technique is obviously not applicable for the 
visualization of bone fractures within a living organism.
The skeletal sites more commonly affected by insufficiency frac-
tures are the lower limbs (tibia, fibula, calcaneus and metatarsus), 
spine (vertebrae) and pelvic region (sacrum, hip and coccyx)32. 
Interestingly, vertebrae are prone to fractures resulting from cyclic 
loading, whereas wrist fractures are mainly associated with single 
loading events37. Most insufficiency fractures in elderly patients 
engaged in exercise, such as marching or running, occur in the 
lower limbs13–15. Insufficiency fractures in the spine and pelvis are 
more common in bedridden individuals in nursing homes, where 
prolonged bed rest can induce loss of bone mass and quality as well 
as muscle atrophy38–40, which is known to affect the levels of strain 
and strain rate in older bone41,42.
Importantly, for elderly patients, insufficiency fractures are indi-
cated as more likely to be the cause of a fall rather than the result of 
Box 1 | Glossary of terms associated with bone fatigue and bone fracture
Cyclic loading: repeated and uctuating loading68–70.
Fracture: complete failure of the material, caused by monotonic 
or cyclic loading68–70.
Fatigue: the process of initiation and propagation of cracks 
resulting from cyclic loading, with a stress magnitude invariably 
below the material’s monotonic strength68–70.
Fragility fracture (medical terminology): pathologic bone 
fracture that occurs when the bone is so fragile that it breaks 
unexpectedly as a result of daily activities. For instance, fragility 
fractures may happen during common events—such as falling 
from a standing position, coughing or sneezing—that would not 
have led to a broken bone in a healthy person.
Stress fracture (medical terminology): fracture of a bone caused 
by cyclic loading. Stress fractures comprise both fatigue fractures, 
which result from vigorous physical activities involving excessive 
cyclic loading on healthy bone, and insuciency fractures, which 
result from everyday activities involving daily cyclic loading on 
weakened bone11, 24,125.
Microcrack: a type of microdamage characterized by a 
microscopic level of matrix failure in bone. Fatigue microcracks 
in bone are oen linear20, 23,55.
Diuse damage: a type of microdamage characterized by patches 
of submicroscopic cracks. Diuse damage is usually observed 
at a level of fatigue damage that is lower than that leading to 
microcracks55.
Crack initiation (stage I): formation and accumulation of small 
damage associated with loss of stiness68–70.
Stable (subcritical) crack growth (stage II): slow and 
incremental crack growth with each cycle of load68–70.
Unstable (critical) crack growth (stage III): crack growth 
causing sudden failure. This occurs when the advancing 
crack has reached a critical size (that is, at the critical fracture 
toughness Kc)
68–70.
Bone mass: amount of mineralized bone material in a given 
volume of interest (one measure of bone quantity).
Bone quality: factors other than bone mass that contribute to 
the bone’s mechanical properties, such as strength and fracture 
resistance. Aspects of bone quality may include collagen-mineral 
composition, multiple-length-scale structure and bone-matrix 
material properties.
Bone resorption: removal of mineralized bone, traditionally 
associated with osteoclast activity. More recently, osteocytes 
have been implicated in bone resorption locally in the lacuna-
canalicular space.
Bone formation: deposition of new bone matrix, usually 
associated with osteoblast activity and recently associated with 
local osteocyte activity.
Bone remodelling: the process of bone resorption followed by 
the formation of new bone.
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it38,43–45. A prospective study of 54 elderly patients with fracture of the 
femoral neck concluded that perhaps a quarter of them had stress 
fractures, which later became fully broken43. These patients described 
their falls as the leg ‘giving way’ after days of growing pain. These sto-
ries were directly related to another case report43 of the same charac-
teristic symptoms of critical crack growth, and in which a radiograph 
of the hip on the day before the fall had revealed a stress fracture.
A few case series have reported the prevalence of insufficiency 
fractures for specific skeletal sites or in specific living conditions. 
For instance, the incidence of insufficiency fracture in the sacrum 
of the elderly has been shown to be between 1% and 5%46–49. In nurs-
ing homes, between 1% and 4% of elderly patients were deemed to 
have suffered insufficiency fractures39,50. These numbers are likely to 
be underestimates, because such fractures are underdiagnosed and 
even undetected. Insufficiency fractures are suspected in one-third 
of patients with pubic fractures46,51 and in one-quarter of patients 
with femoral neck fractures38,43, with more than half of these patients 
having a history of long-bone fractures in the same or surround-
ing bone38, 43,51. This suggests a delay, or even absence, of healing 
from a previous fracture, which leaves a local defect that then can 
act as the source of further fatigue cracks. Consistently, some 50% 
of elderly patients with pelvic insufficiency fractures had not recov-
ered their former level of self-sufficiency after 45 days of hospital-
ization, and 25% of them actually required institutional care40. But 
the most devastating aspect is that patients older than age 50 who 
suffer bone fractures are at a high risk of dying52,53. In fact, the risk 
of mortality in the elderly can increase up to eight-fold in the three 
months following a hip fracture (relative to age-matched and sex-
matched elderly without fractures) due to complications associated 
with healing52. There is thus a clinical need to define the spectrum 
of fatigue-induced fractures more precisely to aid the prevention of 
these fractures, to improve the efficiency of detection and diagnosis 
and, more importantly, to avert the severe problems of delayed heal-
ing and premature death in the elderly population.
The underrated role of cyclic loading
Most of the loads that human bodies carry daily, such as those 
induced by walking, running and jumping, are naturally cyclic. 
Distinct from these are weight-bearing loads, which are static, and 
impact loads, for instance those caused by falls. Human bones are 
naturally programmed to respond to repeated stimuli in the pro-
cess of building a light and resistant skeleton54. Under physiological 
cyclic loading, microdamage is generated in highly stressed regions 
of the skeleton by the mechanism of fatigue17, 18, 23,55. Fatigue dam-
age signals bone cells to repair and replace the bone matrix in these 
regions19,56. It has been shown that cyclic loads (but not static loads) 
resulting from daily activities can stimulate bone formation57,58 
through this damage-repair process, even to the point that cyclic 
loads can accelerate fracture healing58–60.
Despite the clear importance of cyclic loading in the physiologi-
cal function of healthy bone, aged or pathologic bone fracture resis-
tance has primarily been studied as a single loading event, in which 
monotonic axial, bending or torsional testing is used to quantify 
bone stiffness, strength and toughness1,37. Yet insight can be gained 
from cyclic-loading studies of cadaveric human bones investigat-
ing the relationship between age, microdamage and the number of 
cycles sustained before failure (defined as fatigue life). For example, 
age correlates with greater microdamage accumulation and with 
an exponential decrease in fatigue life61. In particular, older human 
bone forms more linear microcracks than young bone, whereas 
young bone tends to form more diffuse damage (that is, clusters of 
nanoscopic cracks) than aged bone61. This appears to be true also in 
in vivo loading conditions23, 62,63. Because in vivo bone has the capac-
ity to undergo repair via osteocytes, osteoblasts and osteoclasts (that 
is, cellular repair), age-related slowdown in cellular repair com-
pounds the age-dependent slowdown of the mechanical response of 
bone to ex vivo cyclic loading64. This implies that, whereas in healthy 
bone microdamage promotes repair and prevents the formation of 
stress fractures, in old or diseased bone unrepaired microdamage 
may turn out to be the very phenomenon that drives damage accu-
mulation into full fractures, as it occurs in engineered materials.
To advance the understanding of the damage mechanisms by 
fatigue and of the role of cyclic loading on bone fractures in healthy 
and fragile bones, it is necessary to explore the concepts of fatigue 
from the viewpoint of fracture mechanics, and compare experi-
mental results from both biological and engineered materials. In 
engineered materials and structures, cyclic fatigue is the most ubiq-
uitous mode of failure. Since it was first recognized in the nineteenth 
century, cyclic fatigue accounts for more than 80% of all failures, 
leading to catastrophic and sudden accidents such as the failure of 
railway axles, the collapse of metallic bridges, the failure of ships and 
the cracking of aircraft airframes and engines. Accordingly, devel-
oping materials with enhanced resistance to fatigue, and devising 
strategies to estimate their safe lifetimes in the presence of fatigue 
loading, has become central to the design of engineered materials, 
and has contributed to the establishment of methods in fracture 
mechanics for the prevention of unexpected fractures.
The fatigue damage of engineered materials occurs in three dis-
crete stages: first, damage is initiated (sometimes over short periods of 
time), invariably at surface imperfections or defects (stage I). Similarly, 
in bone fatigue, damage can initiate between the osteons in the older 
interstitial matrix, which is more mineralized and brittle65,66, causing 
a rapid drop in stiffness23. Once initiated, incipient fatigue cracks pro-
gressively advance by subcritical crack growth (stage II) until a critical 
crack size is reached. At that point, overload fracture (or plastic col-
lapse) ensues in an unstable, sometimes catastrophic, manner (stage 
III). This can occur when the critical stress intensity (at the critical 
fracture toughness Kc), is exceeded. Stages I and III can occur rapidly, 
the stable crack-growth stage often representing the main part of the 
fatigue life in engineered and biological materials. Materials that are 
able to tolerate the presence of damage and subsequent crack growth 
safely until they are repaired are regarded as ‘damage tolerant’.
In many ductile metallic and polymeric materials, the mecha-
nism by which fatigue cracks progress in stage II involves successive 
cycles of plastic blunting during loading, followed by re-sharpening 
of the crack tip during unloading67. Indeed, even though the applied 
cyclic loads cause a nominal stress that is lower than the yield stress 
(that is, the elastic limit of the material), the crack-tip local stresses 
are invariably well above the yield stress, creating a plastic zone. 
These blunting or re-sharpening cycles leave characteristic mark-
ings on the fracture surface of engineered materials and are known 
as ‘fatigue striations’68–71. Each striation is a local measure of the 
crack advance that occurred in that cycle, and thus a persuasive 
proof that the fracture occurred by cyclic fatigue.
Despite the clinical relevance of stress fractures, such a detailed 
mechanistic characterization of fatigue-crack growth in bone is 
unavailable. Nevertheless, stress fractures in bone present some 
common characteristics with fatigue in engineered materials. For 
example, transverse or short, oblique fracture lines with a smooth 
bone fracture surface28, 72,73 are consistent with those frequently 
observed in fatigued metals and alloys68–70. This can be explained by 
the cumulative damage model that described the cycle-dependent 
and time-dependent fracture modes in devitalized cortical bone74. 
In cycle-dependent mechanisms (fatigue mode), the repeated load-
ing and unloading between maximum and minimum stresses drives 
crack growth. In time-dependent mechanisms (creep mode), the 
maximum stress itself expands the crack. The model has shown 
that crack-growth rates are different in the creep (time-dependent) 
and fatigue (cycle-dependent) modes74. Creep damage might leave 
a macroscopically rough crack surface following cement lines and 
cement bands, whereas fatigue damage is associated with smooth 
cracks going through the microstructural constituents, in analogy 
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with fatigue fracture going through the grains of the ductile met-
als68–70. Cycle-dependent (and time-dependent) mechanisms of 
fatigue-crack advance are active in human bone75,76, and alternat-
ing blunting and re-sharpening of the crack tip might be the likely 
mechanism of cyclic crack growth. However, the definitive charac-
teristic striations associated with blunting and re-sharpening have 
not been reported for bone.
In bone, crack advance (stage II) can be characterized by the 
range of stress intensity Δ K, which characterizes the amplitude of 
the local stresses and of displacements in the vicinity of a crack 
tip75. This can be evaluated with the well-known Paris–Erdogan 
law77, which relates Δ K to the crack-growth rate per cycle. The 
Paris–Erdogan law is extensively used for the prediction of fatigue 
lives in engineered materials. In addition, fatigue strength is often 
reported in terms of the Wöhler or S-N curve representing the 
stress range Δ σ or S, at which failure occurs after N cycles dur-
ing experiments. These two fatigue-analysis methods—the for-
mer based solely on crack growth, the latter on total life—suggest 
that fatigue life in bone is likely to be influenced by the loading 
mode65,78, the presence of initial crack-like imperfections, cyclic 
frequency and, most importantly, by the applied cyclic stress (or 
strain) range. Age-related loss of muscle strength and endurance 
are known to increase strain level and strain rate through reduced 
shock absorption41,42. Therefore, change in muscle strength will 
certainly cause a higher cyclic strain range and could thus play a 
critical role in reducing bone fatigue life. However, this is still a 
relatively unexplored area of bone research, as the precise role of 
cyclic loading and corresponding rates of bone fatigue are not well 
documented or understood.
The importance of collagen quality
Clinically, fracture risk is primarily assessed by bone mass or 
bone mineral density (BMD; Box 1) through dual-energy X-ray 
absorptiometry. Although bone fragility is often associated with 
low bone mass79, over half of all non-vertebral fractures in people 
over 55 years of age occurred in those with a clinically normal 
BMD80. Also, a ten-fold increase in fracture risk with age was 
found to be entirely independent of BMD81. In view of this, there 
is an increasing awareness that bone quality (Box 1) plays an addi-
tional, if not greater, role in the occurrence of bone fragility frac-
tures20,82–86. Bone quality is used to describe characteristics of the 
bone other than bone mass (for example, bone matrix material 
properties) that influence the bone’s ability to withstand applied 
loads and displacements. Bone quality is impaired with age, as 
evidenced by the increased amount of microdamage in age-
ing bone61–63. Among the properties of bone, toughness is more 
dramatically reduced with age (a 7–12% decrease in resistance 
to fracture) than stiffness (1–4% decrease in resistance to elas-
tic deformation) and yield strength (2–5% decrease in resistance 
to the onset of plastic deformation)22,87–89. These findings can be 
correlated with those in other studies that have shown that the 
accumulation of fatigue damage affects bone toughness more pro-
foundly than bone stiffness and strength23. This is consistent with 
the finding that ageing impairs bone plasticity and the intrinsic 
toughening mechanisms that alter damage initiation and growth, 
as well as the extrinsic toughening mechanisms that dissipate 
deformation energy during failure90,91.
Bone derives its unique properties from its hierarchical length 
scales, which range from the molecular to the macroscopic, and 
from its graded structure (Fig. 1a). Therefore, to identify the under-
lying determinants of differences in bone quality and fatigue resis-
tance, it is necessary to consider the hierarchical structure of bone. 
At the nanoscale, the ductile collagen phase gives bone its high duc-
tility and toughness, whereas the hard and brittle mineral is respon-
sible for stiffness and strength. At the collagen scale, age impairs 
the ability of collagen fibrils to deform plastically through intrinsic 
toughening mechanisms. This deficit must be compensated at 
higher length scales via energy dissipation through microdamage, 
an extrinsic toughening mechanism90. At the microscale, the osteon 
density is almost three times higher in aged bone than in young 
bone90, which gives rise to more cement lines (that is, the interface 
between osteon and interstitial bone tissue), where fatigue damage 
can form66,90. Therefore, the loss of collagen plasticity and increased 
osteon density contribute to the increased microdamage density 
with age. These findings are consistent with the reduction in crack-
initiation toughness in stage I of the fatigue process. The increased 
osteon density also limits the potency of uncracked-ligament bridg-
ing at the microscale90, which in turn degrades the ultimate crack-
growth toughness during stage III.
The age-related degradation in collagen plasticity is an impor-
tant factor in the loss of fatigue resistance and toughness. Fatigue-
crack growth (stage II) in bone is associated with localized regions 
of plastic deformation in the tip of the crack, primarily taken by 
collagen fibril deformation. When bone material begins to deform 
plastically beyond its yield point, a mechanism of sliding between 
fibrils can ensue. Such ‘fibrillar sliding’ can maintain a constant 
fibril strain and, as such, enables large plastic deformations, thereby 
contributing to bone ductility29, 90,91. Collagen fibrils, as the constitu-
ents where plastic deformations occur, are thus particularly suscep-
tible to fatigue failure92,93.
Ageing and disease can cause several differences in the colla-
gen environment, such as an accumulation of collagen crosslinks, 
variations in the bound water between the collagen and mineral 
phases21,94, and changes in the collagen-degrading matrix metal-
loproteinases95. In addition, levels of non-collagenous proteins 
(osteocalcin and osteopontin)55,96 and crystal size97 contribute to 
differences in bone quality98. Among these factors, the increase of 
collagen crosslinking is a recurrent and important effect in a variety 
of bone fragility diseases. Accumulation of specific collagen cross-
links can stiffen the fibrils and inhibit fibrillar sliding90,99. Collagen 
fibrils are stabilized by enzymatic and non-enzymatic crosslinks 
that form within and between fibrils100–103 (Fig. 1a). Whereas the 
rate of enzymatic crosslinking stabilizes at adolescence104,105, non-
enzymatic crosslinks form the so-called advanced glycation end 
products (AGEs), which accumulate with age by up to five times 
the amount present in young bone90, 100,105–107. AGEs accumulate over 
time in association with reduced bone turnover, oxidative stress 
and dietary glucose intake108. AGE levels thus represent a surrogate 
marker for the age of bone extracellular matrix. AGEs also have the 
capacity to impact cellular function, including that of osteoblasts 
and osteoclasts108–110.
Accordingly, increased non-enzymatic crosslinking in age-
ing cortical bone has been associated with diminished post-yield 
mechanical properties (Fig. 1b), ductility, toughness and fatigue 
resistance, both in human and animal models99,111–115. In the porous 
cancellous bone found within the extremities of long bones, AGEs 
have been shown to accumulate within the centre of the trabecular 
struts, where there is less resistance to fatigue crack expansion116. 
The role of crosslinking on ductility and toughness seems con-
sistent with the bone fragility associated with certain diseases. In 
type 1 diabetes117 and in diabetic obesity, exposure to high levels of 
blood glucose boosts the formation of AGEs118. Under long-term 
antiresorptive treatments, renewal of bone matrix is hampered, 
allowing AGE crosslinking to accumulate29,119 (Fig. 1c). Similar 
elevations in the proportion of AGE crosslinks have been observed 
after irradiation120 (Fig. 1d).
Therefore, AGEs play a causal role in compromising the material 
quality of collagen itself. We believe that excessive non-enzymatic 
crosslinking reduces the critical crack size required for overload 
fracture by lowering the fracture toughness Kc in stage III of the 
fatigue process90. When the crack reaches this size, it can no lon-
ger propagate progressively in fatigue mode, and the remaining 
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cross-section will break in a sudden and brittle way in overload 
mode. As such, a high density of AGEs is likely to allow an incipient 
fatigue crack to cause complete fracture of the bone prematurely.
Consequently, collagen crosslinking may provide a practical 
marker for the prediction of fracture toughness and of fatigue prop-
erties independently of bone mass, both because of its direct role 
in compromising collagen behaviour, and of its indirect association 
with bone age90, 100,105–107. There is some promise that levels of pento-
sidine (a marker for non-enzymatic crosslinking) in serum or urine 
is related to the levels of pentosidine in bone121. If confirmed, this 
could provide a simple test for predicting fracture risk associated 
with non-enzymatic collagen crosslinking. However, more stud-
ies are warranted to investigate the possible relationship between 
fatigue fracture behaviour and the accumulation of non-enzymatic 
collagen crosslinks in bone. An improved understanding of colla-
gen crosslinking and fatigue is needed to advance the development 
of new therapies to restore bone quality and that complement the 
treatment of low bone mass.
Cellular mechanisms of damage repair
Bone stress fractures—that is, both insufficiency fractures and 
fatigue fractures—cannot only be studied from a purely mechanical 
or material perspective. Cortical bone undergoes fatigue damage as a 
result of cyclic loading at physiological stress and strain levels, usually 
under 0.2% strain9,10. At these strain levels, bone samples can sustain 
millions of cycles before failure when tested in vitro (that is, in cadav-
eric bones)11. However, fractures occur after a few hundred thousand 
cycles when applied in vivo11, indicating the need to perform in vivo 
experiments, as in the recently published studies with rodent mod-
els122–124. What is surprising is that the bone repair processes, which 
are active in vivo, would be expected to remove damage and inhibit 
or delay stress fractures (in comparison to in vitro tests); but this is 
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not always the case. This has been explained by means of feedback 
loops that can either promote bone damage or bone repair125. When 
bone resorption exceeds bone formation, the rate of damage forma-
tion increases125. This scenario creates a positive feedback loop that 
boosts the amount of damage. This simplified explanation of damage 
repair mechanisms is, however, not fully satisfying because it does 
not take into account the timing of the repair process nor cell signal-
ling. Here, we use ‘repair cycle’ to describe the process by which the 
damage is repaired normally, as opposed to ‘damage cycle’, where the 
repair cycle is interrupted because loading persists during the tran-
sition between resorption and formation, or because fatigue crack 
formation and growth is faster than the remodelling rate (Fig. 2). 
However, the specific conditions in which in vivo fatigue loading 
can accelerate the occurrence of fatigue failure and the mechanisms 
responsible for this damage cycle remain unclear.
To consider the biological mechanisms that either prevent or pro-
mote fatigue damage, it is worth briefly discussing the basic process 
of remodelling in healthy and fragile bone. Modelling refers to bone-
forming osteoblasts depositing new bone at skeletal sites exposed to 
increased stress or strain and resulting in an updated bone shape, 
whereas remodelling involves bone resorption by osteoclasts, fol-
lowed asynchronously by osteoblastic bone formation. Bone adap-
tation via modelling and remodelling targets, at least partially, the 
repair of damaged regions54. In the elderly and in several conditions 
associated with clinical bone fragility, the rate of bone remodelling is 
low compared to that of young healthy bone. In addition, osteoclast 
activity can be increased compared to osteoblast activity, which often 
leads to loss of bone mass. These conditions are thought to create 
two cumulative detrimental consequences. First, the low bone mass 
induces higher levels of cyclic stress, which allows microdamage to 
initiate and grow more easily. Second, the reduced remodelling rate, 
along with the increased resorption porosities around microdamage, 
stimulates the damage cycle and thus rapid growth of fatigue dam-
age. Moreover, bone quality is reduced with increasing age, in part 
because of a reduction in collagen plasticity90.
Osteocytes, which comprise 90% of the bone cell population, 
are major coordinators of bone remodelling. Embedded within the 
bone matrix, osteocytes are central to bone mechanotransduction 
(the bone’s ability to sense and respond to mechanical stimuli126,127). 
Osteocytes extend tiny dendrite-like processes through canaliculi 
(microscopic channels between the lacunae of ossified bone) to 
communicate with neighbouring osteocytes, osteoblasts, osteo-
clasts and blood vessels (Fig. 2a). Canaliculi are thought to sense 
changes in load and fatigue microdamage that induce resorption 
by osteoclasts56,128–130. Fatigue microcracks, by severing the cana-
liculi, induce the local death of osteocytes through apoptosis11, 23,131. 
Osteocyte apoptosis then triggers the surrounding, surviving osteo-
cytes to express RANKL131, a cytokine that promotes osteoclastic 
bone resorption132. This local increase in bone resorption removes 
microdamage and is normally followed by bone formation in the 
repair cycle. Yet if excessive loading persists during the transi-
tion between resorption and formation, resorption porosities can 
increase the local strains and accelerate the fracture process through 
the damage cycle11,125 (Fig. 2). On the contrary, diffuse damage does 
not seem to affect osteocyte viability nor trigger osteoclastic activity, 
but self-repairs over time23, perhaps via osteocyte-mediated perila-
cunar remodelling. Indeed, osteocytes not only supervise osteoclast 
and osteoblast function, but also actively resorb and replace their 
surrounding bone matrix through perilacunar remodelling95,133–136. 
Osteocyte-mediated perilacunar remodelling plays an essential role 
in the biological control of bone quality. But the extent to which 
damage repair is executed directly by osteoclasts and by osteocytes 
remains an area of active investigation.
Between birth and the age of 80, the percentage of apoptotic 
osteocytes increases to up to ~45% in cortical bone137,138. Age-related 
osteocyte apoptosis is thought to be related to the deterioration in 
the canalicular network, which causes oxygen and nutrient depri-
vation139. Glucocorticoid treatment and diseases (such as osteo-
porosis, osteoarthritis and osteonecrosis) are also associated with 
elevated osteocytic apoptosis136, 140,141. Decreases in the number of 
viable osteocytes and canaliculi limit both the ability of osteocytes 
to sense microdamage and the release of RANKL to recruit osteo-
clasts to repair it136, 142,143. Therefore, deficits in osteocyte function 
contribute in many ways to increased microcrack accumulation143 
and to reduced fatigue resistance in the elderly. Moreover, osteocyte 
lacunae are subject to hypermineralization144, which may provide 
Osteoblasts
Osteoclasts
Osteocytes
Canal
Microcrack
Damage cycle
Repair cycleb
c
Fatigue damagea
Apoptotic
osteocyte
Activation
Repair
area 
Resorption 
Formation
Apoptotic
osteocyte
Resorption 
Activation
Repair
area 
Crack
expansion
Cy
cli
c 
lo
ad
in
g
Fig. 2 | Repair or acceleration of the formation of fatigue cracks. a, Bone cells in bone damaged by a microcrack. b, Repair cycle: the crack is repaired by 
resorption, followed by deposition of new bone. c, Damage cycle: the repair cycle is challenged or interrupted in its resorption phase, leading to stress 
concentration and to the expansion of existing cracks.
NATURE BIOMEDICAL ENGINEERING | VOL 2 | FEBRUARY 2018 | 62–71 | www.nature.com/natbiomedeng 67
© 2018 Macmillan Publishers Limited, part of Springer Nature. All rights reserved.
PERSPECTIVE NATURE BIOMEDICAL ENGINEERING
a preferential crack path for fatigue crack growth, analogously to 
crack growth preceding bone fracture under monotonic loading145.
Insufficiency fractures are believed to result from a high rate of 
fatigue-damage formation that exceeds the rate of immediate bone 
remodelling and repair125. The kinetics of fatigue damage and of 
damage repair, although not fully understood, dictate the fate of a 
loaded bone. Many questions remain about the timing of each stage 
of the repair process, the precise role of each cell type throughout 
the repair process, and the influence of fatigue-loading frequency 
and the recovery time between loadings. This highlights the impor-
tance of carrying out in vivo fatigue studies to ascertain the compet-
ing roles of fatigue damage and cellular repair.
Furthermore, we believe that it is crucial to elucidate the bio-
logical pathways involved in fatigue damage repair. How do remod-
elling factors differ from those involved in single-load-induced 
fracture repair? Several factors are induced in rat models of stress 
fracture; however, few of these (in particular, nitric oxide, sclerostin 
and prostaglandins, which are associated with bone remodelling136) 
have been functionally implicated in the response to fatigue dam-
age. Future work will need to investigate the conditions by which 
fatigue can boost damage repair to prevent stress fracture. Although 
mice provide a powerful genetic model system, rabbit models may 
be more useful, as the Haversian organization of rabbit bone more 
closely resembles that of human bone146. Understanding these con-
ditions may also help elucidate the mechanisms that promote stress 
fracture, and will hopefully guide the development of therapies 
capable of targeting each component of the repair cycle, including 
osteoblasts, osteoclasts and the direct and indirect actions of osteo-
cytes. Combined with exercise, such pathways may be targeted to 
prevent insufficiency fractures and to maintain bone quality over 
nanometric to macrometric length scales in the ageing skeleton.
Prevention and monitoring of insufficiency fractures
There are two ways to combat insufficiency fractures associated 
with bone fragility: either preventing them altogether, or detecting, 
treating and monitoring them.
Prevention. Because an insufficiency fracture is the result of an 
imbalance between cyclic load and damage repair, preventive pro-
grams should focus on restoring the balance between loading and 
repair. Physically active elderly people are less prone to getting 
insufficiency fractures147–149. Therefore, guidance is needed to help 
calibrate a healthy duration and intensity of activity-related load-
ing to the body’s capacity for repair. Although much remains to 
be learned, this can already be achieved in a number of ways. For 
example, the level of applied stress can be limited by using shock-
absorbing shoes on softer surfaces150 and by reducing the intensity 
and duration of sport-led repeated loading to allow time for bone 
repair. Nutritional supplements, namely vitamin D and calcium, are 
highly recommended to prevent bone fracture151,152. Indeed, it has 
been recently shown that vitamin D plays a role in the regulation of 
osteocyte survival and in perilacunar remodelling153, which may be 
pivotal for its capacity to improve bone quality. Preventative steps 
can also minimize the skeletal impact of medical conditions that 
necessitate bed rest. Bedridden elderly people quickly lose muscle 
strength and bone mass.
Detection, monitoring and risk assessment. Following the lessons 
learned from fracture mechanics with composite materials, a ‘dam-
age tolerant’ approach could be opted for; that is, the monitoring of 
damage accumulation and the limiting of critical damage growth 
instead of the prevention of damage formation. On the basis of the 
level of detected fatigue damage, the risk of fatigue-induced fracture 
can be assessed and repair actions taken. In structural engineering, 
most crack detection is performed by visual inspection of critical 
sites, aided by detection techniques such as alternating current or 
ultrasonic testing. Ideally, in vivo fatigue cracking would be moni-
tored on a yearly basis using radiation-free and affordable imaging 
that achieves the sensitivity currently available only with MRI or 
high-resolution computed tomography. An optical sensor consist-
ing of a laser and a camera that can affordably distinguish between 
broken and unbroken bones without radiation154 shows promise, 
but this technique has not yet been tested on insufficiency fractures.
Another approach for assessing in vivo fracture risk would be to 
measure the critical fracture toughness, which defines the transition 
from progressive crack growth to catastrophic failure. To that end, 
since the early 1900s, hardness indentation tests have been used 
to quantify hardness and elastic modulus. The osteopenetrometer, 
developed in the 1980s, was based on this technique to measure tra-
becular bone strength during surgical procedures155. More recently, 
reference point indentation (RPI), an in vivo microindentation tech-
nique, has been shown to collect outcomes that (in its first version) 
correlate with a reduction in bone toughness21,156–158. In studies on 
aged patients156, the increase in indentation distance of the RPI was 
found to correlate negatively with crack-growth toughness (patients 
with osteoporotic fractures had a 47% greater increase in indenta-
tion distance compared to age-matched controls). A newer version 
of the RPI159,160 was designed as a single-impulse indentation, which 
resembles more that of impact testers (such as the Charpy test devel-
oped in the early 1900s). Impact tests have been used to measure the 
energy absorbed during dynamic fracture and specifically to study 
the ductile–brittle transition. Although the outcomes of the newer 
RPI have not yet been compared with traditional mechanical prop-
erties159,160, they should mainly reflect pre-yield properties, because 
post-yield and extrinsic toughening mechanisms are diminished in 
bone at high strain rates161,162.
Although these techniques appear to be promising as clinical 
measurements of fracture risk in living patients, the mechanisms 
that they are investigating have not yet been shown to correlate with 
fatigue fracture mechanisms. Furthermore, these measures are lim-
ited to a local region of the tibial cortical bone, yet are performed as 
a blind test with the nominal assumption of homogeneous mechan-
ical properties. Moreover, the use of these techniques is question-
able on aged bone, where microindenting and impacting could be 
the loading event that triggers fracture of bone weakened by fatigue 
damage accumulation.
Levels of non-enzymatic collagen crosslinking may also pro-
vide a practical marker to predict fracture risk. Other biochemical 
markers (such as oestradiol, dehydroepiandrosterone sulfate, sex-
hormone-binding globulin and parathyroid hormone) might also 
be an effective means to monitor bone remodelling and metabolism 
and to evaluate the risk of insufficiency fracture163.
The future of the prevention of insufficiency fractures may 
involve all these parameters and rely on the use of health monitoring 
systems. Simple bone health parameters such as vital signs, weight, 
age, levels of activity (including exercise, bed-rest time and the pres-
ence of extreme loadings), food intake and nutritional supplement 
intake, as well as medical information such as that from bone imag-
ing, bone densitometry, in vivo microindentation outcomes, blood 
tests and treatments, could be monitored. Statistical analysis of sen-
sitive parameters would then provide a prediction of the patient’s 
bone health as well as key strategies for maintaining bone integrity.
Outlook
The interactions between cyclic loading, fatigue damage and repair 
processes are complex. In this Perspective, we have provided evi-
dence that suggests that insufficiency fractures in the elderly pop-
ulation might be the result of an imbalance between damage and 
repair dynamics that are highly sensitive to changes in bone quality, 
bone mass and remodelling with age. To unravel the complexities, 
we are proposing to approach this problem from a somewhat differ-
ent viewpoint. On the basis of case studies, we postulate that bone 
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fractures in the elderly, perhaps for a quarter of them, are insuf-
ficiency fractures caused by cyclic loads inducing fatigue crack-
ing, and not necessarily following impacts or trauma. We have also 
presented the concepts of fatigue crack growth, inherited from 
the fracture mechanics of non-biological materials, and discussed 
experimental clues that indicate that bone might have similar fatigue 
behaviour in vitro. We believe that it is imperative to investigate the 
deterioration in bone quality in aged bones. The loss of collagen 
plasticity, combined with increased osteon density, plays important 
roles in the increase of microdamage density with age. This might 
explain how an incipient fatigue crack can cause the complete frac-
ture of aged bone prematurely.
Cellular mechanisms act to repair fatigue damage in vivo and 
prevent stress fractures (the repair cycle). However, in ageing or in 
conditions of bone fragility, the timing of repair is challenged by 
excessive rates of fatigue damage formation or by low turnover rate. 
In these circumstances, the cellular mechanisms of repair are insuf-
ficient and the fatigue damage propagation is accelerated (the dam-
age cycle). The biological pathways and the time-dependencies of 
the repair and damage cycles still need to be elucidated. Osteocytes 
are already known to be involved in the activation of bone resorp-
tion and formation around damage. New evidence indicates that 
they are also actors in the local remodelling process. Nonetheless, 
there are still major gaps in the understanding of the role of osteo-
cytes in damage repair. Future clinical indicators of fracture risk will 
be based on bone quality, such as serum or urine markers of bone 
remodelling or collagen crosslinking, on new imaging modalities, 
or on in vivo microindentation techniques, instead of relying solely 
on bone mass. And new therapeutic treatments that stimulate the 
cellular repair of fatigue damage may restore bone quality, or at least 
prevent its degeneration.
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